Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic

Neuromyelitis optica spectrum disorder (NMOSD) can lead to immobility and bulbar weakness. This, in addition to the older age of onset and the higher rate of hospitalization compared to multiple sclerosis, makes this patient group a potential target for complicated COVID-19 infection. Moreover, many...

Descripción completa

Detalles Bibliográficos
Autores principales: Abboud, Hesham, Zheng, Crystal, Kar, Indrani, Chen, Claire Kaori, Sau, Crystal, Serra, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265855/
https://www.ncbi.nlm.nih.gov/pubmed/32526698
http://dx.doi.org/10.1016/j.msard.2020.102249

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7265855/
https://www.ncbi.nlm.nih.gov/pubmed/32526698
http://dx.doi.org/10.1016/j.msard.2020.102249

Ejemplares similares